Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
First robotic nipple-sparing mastectomy performed in New York City

First robotic nipple-sparing mastectomy performed in New York City

New method maps CRISPR off-target edits at single-cell resolution

New method maps CRISPR off-target edits at single-cell resolution

Newly identified enzyme protects growth protein in leukemia cells

Newly identified enzyme protects growth protein in leukemia cells

Childhood cancer survival reaches nearly 90%, yet disparities remain

Childhood cancer survival reaches nearly 90%, yet disparities remain

Oral leukemia therapy offers effective at-home care for older adults

Oral leukemia therapy offers effective at-home care for older adults

New patient-centered initiative aims to accelerate pediatric AML research and treatments

New patient-centered initiative aims to accelerate pediatric AML research and treatments

‘Fossil record’ in stored blood samples lets scientists trace leukemia back decades before diagnosis

‘Fossil record’ in stored blood samples lets scientists trace leukemia back decades before diagnosis

Towards a new approach to treating chronic blood disorders

Towards a new approach to treating chronic blood disorders

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Natural plant extract reduces cisplatin-induced kidney injury in mice

Natural plant extract reduces cisplatin-induced kidney injury in mice

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

Tumor mutations may help predict relapse risk in childhood leukemia

Tumor mutations may help predict relapse risk in childhood leukemia

Plant-derived compound helps restore cancer cells' sensitivity to treatment

Plant-derived compound helps restore cancer cells' sensitivity to treatment

Study identifies common mechanism behind widespread cancer mutations

Study identifies common mechanism behind widespread cancer mutations

Lab-on-a-chip technology helps predict childhood leukemia treatment responses

Lab-on-a-chip technology helps predict childhood leukemia treatment responses

Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia

Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia

Blood Cancer United awards grant to diversify clinical trial access

Blood Cancer United awards grant to diversify clinical trial access

Scientists identify novel autoimmune driver behind DNA repair breakdown in childhood cancer

Scientists identify novel autoimmune driver behind DNA repair breakdown in childhood cancer

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

Enhanced CAR T-cell therapy may improve treatment options for patients with B-cell blood cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.